Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TG103 in type 2 diabetes with overweight/obesity
CTR20212332Phase 2Completed
- Sponsor
- Chengdu Tianshizhen Biotechnology
- Start
- Sep 2021
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of GX-G6 in type 2 diabetes mellitus (T2DM), Overweight, obesity, sponsored by Chengdu Tianshizhen Biotechnology. Started Sep 2021; status: completed.
02
Drugs
GX-G6
03
Conditions
type 2 diabetes mellitus (T2DM)Overweightobesity
Beyond the preview
Go deeper on CTR20212332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20212332.